Human Papillomavirus (HPV) Vaccines Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Human Papillomavirus (HPV) Vaccines Marketed and Pipeline Drugs Report Overview
HPV is a common virus that can affect different parts of the body. There are several types of HPV, including strains of HPV that cause warts on the hands, feet, and face, and about 30 HPV strains that can affect the genitals. Early detection and treatment of HPV can usually prevent the progression to cancer from happening. The virus remains relatively inactive in early infection but keeps the cell from entering a resting (G0) state.
The Human Papillomavirus (HPV) Vaccines marketed and pipeline drugs market research report includes an assessment of the disease epidemiology, leading marketed products with sales forecast, pricing and reimbursement, and late-to-mid-stage pipeline products with phase transition success rate (PTSR), and the likelihood of approval (LoA) for human papillomavirus (HPV) vaccines. The report also analyzes the clinical and commercial landscapes of HPV, as well as an assessment of deals, future market catalysts, key market players, and the future competitive environment.
Key Routes of Administration
(Pipeline Drugs) |
· Injection
· Oral |
Top Sponsors (Marketed
and Pipeline Drugs) |
· Merck & Co
· Shanghai Bovax Biotechnology Co Ltd · Xiamen University · Beijing Health Guard Biotechnology Inc · Shanghai Zerun Biotechnology Co Ltd · National Cancer Institute US · University of Washington |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
HPV Vaccines Pipeline Drugs Segmentation by Routes of Administration
The key routes of administration for Human Papillomavirus (HPV) vaccines pipeline drugs are injection and oral. In 2023, most of the pipeline drugs in the HPV vaccines landscape are administered by injections.
HPV Vaccines Pipeline Drugs Analysis by RoA, 2023 (%)
For more RoA insights into the HPV vaccines pipeline drugs market, download a free report sample
Top Sponsors in the HPV Vaccines Marketed and Pipeline Drugs Market
Some of the top sponsors in the Human Papillomavirus (HPV) vaccines marketed and pipeline drugs market are Merck & Co, Shanghai Bovax Biotechnology Co Ltd, Xiamen University, Beijing Health Guard Biotechnology Inc, Shanghai Zerun Biotechnology Co Ltd, National Cancer Institute US, and the University of Washington. Merck & Co sponsored the highest number of trials, followed by Shanghai Bovax Biotechnology. Merck & Co also sponsored the highest number of Phase III trials.
HPV Vaccines Pipeline Drugs Analysis by Sponsors, 2023 (%)
For more sponsor insights into the HPV vaccines pipeline drugs market, download a free report sample
Segments Covered in the Report
HPV Vaccines Pipeline Drugs Routes of Administration Outlook (Number of Drugs, 2023)
- Injection
- Oral
Scope
GlobalData’s HPV Vaccines Marketed and Pipeline Drugs Assessment, Clinical Trials, and Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.
Components of the report include –
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Breakdown by Route of Administration
- Product Profiles with Sales Forecast
- Pricing and Reimbursement Assessment
- Annual Therapy Cost
- Time to Pricing and Time to Reimbursement
- Pipeline Assessment
- Breakdown by Development Stage, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Late-to-mid-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the HPV Vaccines market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global HPV Vaccines market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
Frequently asked questions
-
Which RoA for Human Papillomavirus (HPV) vaccines pipeline drugs accounts for the highest share?
In 2023, for all the HPV pipeline drugs, injection is the most common route of administration.
-
Who are the top sponsors for Human Papillomavirus (HPV) vaccines marketed and pipeline drugs market?
Some of the top sponsors in the HPV vaccines marketed and pipeline drugs market are Merck & Co, Shanghai Bovax Biotechnology Co Ltd, Xiamen University, Beijing Health Guard Biotechnology Inc, Shanghai Zerun Biotechnology Co Ltd, National Cancer Institute US, and the University of Washington.
-
Which player sponsored the highest number of trials for HPV vaccines marketed and pipeline drugs?
Merck & Co sponsored the highest number of trials for HPV vaccines marketed and pipeline drugs.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Human Papillomavirus Infections reports

